High-quality cancer care must include palliative care in addition to the more traditional care, such as oncology, radiology, surgery, and imaging, Toby C. Campbell, MD, MSCI, associate professor of medicine, hematology-oncology at the University of Wisconsin School of Medicine and Public Health and chief of Palliative Care and program director of the Hospice and Palliative Medicine Fellowship Training Program, said at the National Comprehensive Cancer Network Annual Conference.
High-quality cancer care must include palliative care in addition to the more traditional care, such as oncology, radiology, surgery, and imaging, Toby C. Campbell, MD, MSCI, associate professor of medicine, hematology-oncology at the University of Wisconsin School of Medicine and Public Health and chief of Palliative Care and program director of the Hospice and Palliative Medicine Fellowship Training Program, said at the National Comprehensive Cancer Network Annual Conference.
Transcript (slightly modified)
What has been a key takeaway from the NCCN meeting regarding the discussion on palliative care?
What we've been talking about at NCCN here is the highest quality cancer care and it's really clear that if you want to deliver high-quality cancer care, that includes not only the traditional components like good oncology and radiology and surgery and imaging, but also palliative care. And palliative care delivered by a multi-disciplinary team, which might include a physician and nurse practictioner, but also a social worker or nurse, and that kind of resources that are brought to bear for a patient and family really are a core component of high-quality cancer care.
Do you find the topic of palliative care is more commonly brought up by a nurse or other caregiver on the patient's team?
Palliative care comes up in a variety of circumstances. Sometimes it's the nurse in the chemotherapy room. Sometimes it's the provider. So I think discussions of a palliative nature come up in lots of different contexts. Sometimes it rises to the level where a subspecialists in palliative care becomes a part of the team. And that, too, can be brought up by any number of individuals, including the patients and families themselves.
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Ways Providers, Payers Can Ensure Biomarker Testing Is Done in Cancer Care
October 18th 2024There is a role for both payers and providers to make small changes that would increase the use of biomarker testing to ensure patients are receiving the appropriate treatment, said Susan Wescott, RPh, MBA, senior director of managed care pharmacy, Mayo Clinic.
Read More